Author:
Nadler Roland C,Reiner Peter B
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health(social science)
Reference5 articles.
1. Amarin Corporation. (2008) Amarin to commence phase II trial with AMR101 in age associated memory impairment. January 2010, http://www.amarincorp.com/investor_relations/press-releases/2008/2008-commence-phase2-amr101-age-assoc-mem-impairment.htmlaccessed 6 May 2010.
2. Burgin, A. et al (2009) Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety. Nature Biotechnology 28(1): 63–72.
3. Helicon Therapeutics. (2008) Helicon study of HT-0712 on primate memory formation reveals significant enhancement. 22 July, http://www.helicontherapeutics.com/cgi-bin/main.pl?section=News;page=Press_releases , accessed 6 May 2010.
4. Nowotny, H. (2008) Insatiable Curiosity: Innovation in a Fragile Future, Translated by M. Cohen. Cambridge, MA: MIT.
5. Quednow, B.B. (2010) Ethics of neuroenhancement: A phantom debate. BioSocieties 5 (1): 153–156.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献